142
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system

, , &
Pages 2253-2263 | Published online: 29 Mar 2019

References

  • BerthetMGauthierYLacroixCVerrierBMongeCNanoparticle-based dressing: the future of wound treatment?Trends Biotechnol201735877078428645529
  • PachuauLRecent developments in novel drug delivery systems for wound healingExpert Opin Drug Deliv201512121895190926289672
  • NairKLJagadeeshanSNairSAKumarGSBiological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGAInt J Nanomedicine201161685169721980233
  • SongRMurphyMLiCTingKSooCZhengZCurrent development of biodegradable polymeric materials for biomedical applicationsInt J Nanomed20181231173145
  • BeckertSFarrahiFAslamRSLactate stimulates endothelial cell migrationWound Repair Regen200614332132416808811
  • MilovanovaTNBhopaleVMSorokinaEMLactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1Mol Cell Biol200828206248626118710947
  • JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249011055295
  • ChereddyKKHerCHComuneMPLGA nanoparticles loaded with host defense peptide LL37 promote wound healingJ Control Release201419413814725173841
  • ChereddyKKLopesAKoussoroplisSCombined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic woundsNanomedicine20151181975198426238081
  • ChereddyKKCocoRMemvangaPBCombined effect of PLGA and curcumin on wound healing activityJ Control Release2013171220821523891622
  • JiangBZhangGBreyEMDual delivery of chlorhexidine and platelet-derived growth factor-BB for enhanced wound healing and infection controlActa Biomater2013924976498423063555
  • WysockiABWound fluids and the pathogenesis of chronic woundsJ Wound Ostomy Continence Nurs19962362832909043277
  • HardingKGMorrisHLPatelGKScience, medicine and the future: healing chronic woundsBMJ2002324733016016311799036
  • BarrientosSStojadinovicOGolinkoMSBremHTomic-CanicMGrowth factors and cytokines in wound healingWound Repair Regen200816558560119128254
  • GalianoRDTepperOMPeloCRTopical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cellsAm J Pathol200416461935194715161630
  • BaoPKodraATomic-CanicMGolinkoMSEhrlichHPBremHThe role of vascular endothelial growth factor in wound healingJ Surg Res2009153234735819027922
  • WernerSGroseRRegulation of wound healing by growth factors and cytokinesPhysiol Rev200383383587012843410
  • MccartySMPercivalSLProteases and delayed wound healingAdv Wound Care201328438447
  • LiuJZhengHDaiXSunSMachensHGSchillingAFBiomaterials for promoting wound healing in diabetesJ Tissue Sci Eng201781193196
  • RhoadsDDWolcottRDPercivalSLBiofilms in wounds: management strategiesJ Wound Care2008171150250818978690
  • LipskyBAHoeyCTopical antimicrobial therapy for treating chronic woundsClin Infect Dis200949101541154919842981
  • HancockRESahlHGAntimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNat Biotechnol200624121551155717160061
  • MarrAKGooderhamWJHancockREAntibacterial peptides for therapeutic use: obstacles and realistic outlookCurr Opin Pharmacol20066546847216890021
  • GaldieroSFalangaABerisioRGriecoPMorelliGGaldieroMAntimicrobial peptides as an opportunity against bacterial diseasesCurr Med Chem201522141665167725760092
  • BlondelleSELohnerKCombinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studiesBiopolymers2000551748710931443
  • DuvalEZatylnyCLaurencinMBaudy-Floc’hMHenryJKKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activityPeptides20093091608161219573572
  • DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
  • BehrendtRWhitePOfferJAdvances in Fmoc solid-phase peptide synthesisJ Pept Sci201622142726785684
  • AshwanikumarNKumarNANairSAKumarGSVPhenylalanine-containing self-assembling peptide nanofibrous hydrogel for the controlled release of 5-fluorouracil and leucovorinRSC Advances20144552915729164
  • CsabaNGonzálezLSánchezAAlonsoMJDesign and characterisation of new nanoparticulate polymer blends for drug deliveryJ Biomater Sci Polym Ed20041591137115115503631
  • MathewAFukudaTNagaokaYCurcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s diseasePLoS One201273e3261622403681
  • Zanetti-RamosBGFritzen-GarciaMBde OliveiraCSDynamic light scattering and atomic force microscopy techniques for size determination of polyurethane nanoparticlesMater Sci Eng C2009292638640
  • Ashikari-HadaSHabuchiHKariyaYKimataKHeparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparinsJ Biol Chem200528036315083151516027124
  • NugentMAIozzoRVFibroblast growth factor-2Int J Biochem Cell Biol200032211512010687947
  • BrandnerBKurkelaRVihkoPKunglAJInvestigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfoldingBiochem Biophys Res Commun2006340383683916386708
  • GainzaGVillullasSPedrazJLHernandezRMIgartuaMAdvances in drug delivery systems (DDSs) to release growth factors for wound healing and skin regenerationNanomed Nanotechnol201511615511573
  • ChenRRMooneyDJPolymeric growth factor delivery strategies for tissue engineeringPharm Res20032081103111212948005
  • LiuYWuXMiYPLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studiesDrug Deliv201724144345128165858
  • RuGHanLQingJEffects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administrationDrug Deliv20162393417342327174642
  • TrengoveNJStaceyMCMacauleySAnalysis of the acute and chronic wound environments: the role of proteases and their inhibitorsWound Repair Regen19997644245210633003
  • KingTWPatrickCWDevelopment and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction techniqueJ Biomed Mater Res200051338339010880080
  • JoungYKBaeJWParkKDControlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regenerationExpert Opin Drug Deliv20085111173118418976129
  • MangoniMLMcdermottAMZasloffMAntimicrobial peptides and wound healing: biological and therapeutic considerationsExp Dermatol201625316717326738772
  • GuilhelmelliFVilelaNAlbuquerquePDerengowskiLSSilva-PereiraIKyawCMAntibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceFront Microbiol2013435324367355
  • LegrandBLaurencinMSarkisJStructure and mechanism of action of a de novo antimicrobial detergent-like peptideBiochim Biophys Acta20111808110611620833125